scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
Over the last 12 months, insiders at scPharmaceuticals Inc. have bought $0 and sold $0 worth of scPharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at scPharmaceuticals Inc. have bought $7.77M and sold $1.56M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 762,380 shares for transaction amount of $4M was made by ORBIMED ADVISORS LLC (director) on 2022‑11‑25.
2022-11-25 | ORBIMED ADVISORS LLC | director | 762,380 1.7007% | $5.25 | $4M | +1.99% | ||
2022-10-10 | Sale | Schwab Andrew J. | director | 562,466 1.831% | $4.09 | $2.3M | +91.04% | |
2022-10-06 | Sale | Schwab Andrew J. | director | 37,534 0.1225% | $5.02 | $188,421 | +56.10% | |
2022-09-06 | Sale | Schwab Andrew J. | 6,793 0.022% | $4.75 | $32,267 | +43.28% | ||
2022-04-11 | Sale | Schwab Andrew J. | 220,096 0.776% | $5.00 | $1.1M | +10.62% | ||
2021-12-03 | Tucker John H | President and CEO | 10,000 0.0373% | $3.96 | $39,553 | +30.15% | ||
2021-12-03 | Khattar Jack A. | director | 5,000 0.0184% | $3.91 | $19,569 | +30.15% | ||
2021-03-15 | Sale | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 110,588 0.3963% | $7.03 | $777,788 | -20.33% | |
2021-03-12 | Sale | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 39,469 0.1461% | $7.22 | $284,816 | -19.78% | |
2020-05-26 | Schwab Andrew J. | 10 percent owner | 578,034 2.5395% | $8.65 | $5M | -12.34% | ||
2020-05-21 | ORBIMED ADVISORS LLC | 10 percent owner | 1.39M 6.0411% | $8.65 | $12M | -12.99% | ||
2020-02-14 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 271,993 1.2768% | $8.20 | $2.23M | -7.06% | ||
2019-12-13 | Tucker John H | President and CEO | 5,000 0.0266% | $5.24 | $26,189 | +52.26% | ||
2019-04-11 | RA CAPITAL MANAGEMENT, LLC | 10 percent owner | 389,862 2.1623% | $2.70 | $1.05M | +109.92% | ||
2017-11-21 | ORBIMED ADVISORS LLC | 10 percent owner | 833,333 9.7286% | $14.00 | $11.67M | -28.96% | ||
2017-11-21 | Lundbeckfond Invest A/S | 10 percent owner | 1.31M 15.2879% | $14.00 | $18.33M | -28.96% | ||
2017-11-21 | Agger Mette Kirstine | 1.31M 15.2879% | $14.00 | $18.33M | -28.96% | |||
2017-11-21 | 5AM Partners IV, LLC | 10 percent owner | 1.31M 7.6439% | $7.00 | $9.17M | -28.96% | ||
2017-11-21 | SUN PHARMACEUTICAL INDUSTRIES LTD | 10 percent owner | 714,286 8.3388% | $14.00 | $10M | -28.96% |
ORBIMED ADVISORS LLC | director | 5328328 14.8585% | $4.44 | 3 | 0 | <0.0001% |
Agger Mette Kirstine | 3183986 8.8788% | $4.44 | 1 | 0 | <0.0001% | |
Lundbeckfond Invest A/S | 10 percent owner | 3183986 8.8788% | $4.44 | 1 | 0 | <0.0001% |
5AM Partners IV, LLC | 10 percent owner | 3123302 8.7096% | $4.44 | 1 | 0 | <0.0001% |
RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2727446 7.6057% | $4.44 | 2 | 2 | +51.43% |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10 percent owner | 357143 0.9959% | $4.44 | 1 | 0 | <0.0001% |
Schwab Andrew J. | director | 92983 0.2593% | $4.44 | 1 | 4 | <0.0001% |
Tucker John H | President and CEO | 46962 0.131% | $4.44 | 2 | 0 | +41.21% |
Khattar Jack A. | director | 5000 0.0139% | $4.44 | 1 | 0 | +30.15% |
OrbiMed | $27.91M | 15.42 | 5.56M | 0% | +$0 | 0.57 | |
Helm Capital Management LLC | $17.7M | 9.78 | 3.52M | +0.71% | +$125,500.00 | 0.52 | |
Aigh Capital Management Llc | $17.01M | 9.4 | 3.39M | +9.09% | +$1.42M | 10.1 | |
BlackRock | $9.04M | 5 | 1.8M | -3.32% | -$310,381.57 | <0.0001 | |
Luther King Capital Management | $7.29M | 4.03 | 1.45M | +4.28% | +$299,242.21 | 0.03 | |
The Vanguard Group | $6.88M | 3.8 | 1.37M | <0.01% | -$261.04 | <0.0001 | |
5Am Venture Management Llc | $6.03M | 3.33 | 1.2M | 0% | +$0 | 0.41 | |
J. Goldman & Company | $5.62M | 3.1 | 1.12M | -20.36% | -$1.44M | 0.26 | |
Thrivent Financial For Lutherans | $5.36M | 2.96 | 1.07M | +1.65% | +$86,853.39 | 0.01 | |
Tejara Capital Ltd | $3.5M | 1.94 | 698,186 | -7.86% | -$299,116.72 | 1.19 | |
Citadel Advisors LLC | $2.9M | 1.6 | 576,913 | +313.57% | +$2.2M | <0.01 | |
State Street | $2.89M | 1.6 | 575,266 | +2.67% | +$75,018.87 | <0.0001 | |
Walleye Capital | $2.79M | 1.54 | 556,186 | -33.7% | -$1.42M | 0.01 | |
Geode Capital Management | $2.72M | 1.5 | 541,843 | +0.76% | +$20,559.12 | <0.0001 | |
Stonepine Capital Management Llc | $2.24M | 1.24 | 446,776 | New | +$2.24M | 1.81 | |
Rice Hall James & Associates, LLC | $1.41M | 0.78 | 281,105 | +247.03% | +$1M | 0.09 | |
Northern Trust | $1.33M | 0.73 | 264,809 | -1.57% | -$21,219.54 | <0.0001 | |
Renaissance Technologies | $1.19M | 0.65 | 235,958 | +463.15% | +$974,574.84 | <0.01 | |
Kennedy Capital Management Inc | $1.1M | 0.61 | 219,754 | -1.46% | -$16,294.92 | 0.02 | |
Millennium Management LLC | $949,202.00 | 0.52 | 189,084 | -47.02% | -$842,301.06 | <0.01 | |
Bridgeway Capital Management | $948,780.00 | 0.52 | 189,000 | +31.25% | +$225,900.00 | 0.02 | |
Morgan Stanley | $907,214.00 | 0.5 | 180,720 | -9% | -$89,687.28 | <0.0001 | |
Dimensional Fund Advisors | $834,405.00 | 0.46 | 166,216 | -4.24% | -$36,932.17 | <0.0001 | |
Nuveen | $454,325.00 | 0.25 | 90,503 | 0% | +$0 | <0.0001 | |
Ameriprise Financial | $431,031.00 | 0.24 | 85,863 | -2.29% | -$10,085.15 | <0.0001 | |
Raymond James Associates | $426,946.00 | 0.24 | 85,049 | -2.3% | -$10,040.00 | <0.0001 | |
BNY Mellon | $375,658.00 | 0.21 | 74,832 | -8.21% | -$33,624.08 | <0.0001 | |
Charles Schwab | $364,241.00 | 0.2 | 72,558 | -6.27% | -$24,362.05 | <0.0001 | |
Squarepoint Ops LLC | $312,560.00 | 0.17 | 62,263 | +24.39% | +$61,289.13 | <0.01 | |
Thomasville National Bank | $184,736.00 | 0.1 | 36,800 | +11.52% | +$19,076.00 | 0.02 | |
RhumbLine Advisers | $182,926.00 | 0.1 | 36,441 | +2.12% | +$3,794.96 | <0.0001 | |
Jane Street Capital | $177,994.00 | 0.1 | 35,457 | +48.47% | +$58,106.45 | <0.0001 | |
UBS | $171,854.00 | 0.1 | 34,234 | +16.07% | +$23,789.69 | <0.0001 | |
Connor Clark & Lunn Investment Management Ltd | $163,311.00 | 0.09 | 32,532 | New | +$163,311.00 | <0.0001 | |
Goldman Sachs | $142,312.00 | 0.08 | 28,349 | -37.27% | -$84,571.95 | <0.0001 | |
Bank of America | $141,961.00 | 0.08 | 28,279 | -13.19% | -$21,560.96 | <0.0001 | |
Susquehanna International Group | $134,978.00 | 0.08 | 26,888 | -58.45% | -$189,901.92 | <0.0001 | |
Mitsubishi UFJ Kokusai Asset Management | $103,583.00 | 0.06 | 20,634 | -21.25% | -$27,951.45 | <0.0001 | |
Barclays | $102,000.00 | 0.06 | 20,304 | -48.84% | -$97,363.18 | <0.0001 | |
Assenagon Asset Management S.A. | $99,506.00 | 0.06 | 19,822 | New | +$99,506.00 | <0.0001 | |
Virtu Financial Llc | $90,000.00 | 0.05 | 17,895 | New | +$90,000.00 | 0.01 | |
MetLife Investment Management | $76,826.00 | 0.04 | 15,304 | -0.12% | -$95.38 | <0.0001 | |
Sherbrooke Park Advisers Llc | $72,398.00 | 0.04 | 14,422 | New | +$72,398.00 | 0.01 | |
Deutsche Bank | $71,947.00 | 0.04 | 14,332 | +806.51% | +$64,010.34 | <0.0001 | |
CAPTRUST | $70,546.00 | 0.04 | 14,053 | New | +$70,546.00 | <0.0001 | |
American International Group | $71,445.00 | 0.04 | 14,232 | -0.86% | -$617.46 | <0.0001 | |
Invesco | $63,769.00 | 0.04 | 12,703 | -0.56% | -$361.44 | <0.0001 | |
The Manufacturers Life Insurance Company | $61,751.00 | 0.03 | 12,301 | +0.77% | +$471.88 | <0.0001 | |
JPMorgan Chase | $60,285.00 | 0.03 | 12,009 | -38.73% | -$38,101.69 | <0.0001 | |
IPG INVESTMENT ADVISORS, LLC | $60,240.00 | 0.03 | 12,000 | 0% | +$0 | 0.01 |